In: Opinions & Features

03.23.2121 | Forbes

By Steve Brozak

“Late Monday, the Data and Safety Monitoring Board notified NIAID, BARDA, and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its Covid-19 vaccine clinical trial.” This quote from, highlights how important the availability of reliable and timely data collection and analysis for our pandemic response. This commentary will not weigh in on whether the AstraZeneca Covid-19 vaccine will ultimately receive the FDA’s Emergency Use Authorization, but it has to highlight the criticality of reliable and timely data collection and analysis in dealing with this pandemic.

In 1996, Alan Greenspan popularized the term irrational exuberance. He cautioned how unfounded market optimism that lacked a real foundation of fundamentals, but instead rested on psychological factors, was a great danger. Based on carefully presented data, he detailed the danger of the then burgeoning internet bubble. Today, that the phenomenon bears eerie similarities to the attitudes of many as they react to the continuing SARS-CoV-2 pandemic.

To read the entire article on Forbes, Please click here…